Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Analysis of genotype-phenotype correlations and survival outcomes in patients with primary hyperparathyroidism caused by multiple endocrine neoplasia type 1: the experience at a single institution.

Horiuchi K, Okamoto T, Iihara M, Tsukada T.

Surg Today. 2013 Aug;43(8):894-9. doi: 10.1007/s00595-012-0354-y. Epub 2012 Oct 9. Erratum in: Surg Today. 2013 Aug;43(8):900.

PMID:
23052745
2.

Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.

Goroshi M, Bandgar T, Lila AR, Jadhav SS, Khare S, Shrikhande SV, Uchino S, Dalvi AN, Shah NS.

Fam Cancer. 2016 Oct;15(4):617-24. doi: 10.1007/s10689-016-9891-7.

PMID:
26905068
3.

Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).

Gaztambide S, Vazquez F, Castaño L.

Minerva Endocrinol. 2013 Mar;38(1):17-28. Review.

PMID:
23435440
4.

Genotype-phenotype analysis in multiple endocrine neoplasia type 1.

Kouvaraki MA, Lee JE, Shapiro SE, Gagel RF, Sherman SI, Sellin RV, Cote GJ, Evans DB.

Arch Surg. 2002 Jun;137(6):641-7.

PMID:
12049533
5.

Genotype/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas.

Goebel SU, Heppner C, Burns AL, Marx SJ, Spiegel AM, Zhuang Z, Lubensky IA, Gibril F, Jensen RT, Serrano J.

J Clin Endocrinol Metab. 2000 Jan;85(1):116-23.

PMID:
10634374
7.

Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders.

Giraud S, Zhang CX, Serova-Sinilnikova O, Wautot V, Salandre J, Buisson N, Waterlot C, Bauters C, Porchet N, Aubert JP, Emy P, Cadiot G, Delemer B, Chabre O, Niccoli P, Leprat F, Duron F, Emperauger B, Cougard P, Goudet P, Sarfati E, Riou JP, Guichard S, Rodier M, Meyrier A, Caron P, Vantyghem MC, Assayag M, Peix JL, Pugeat M, Rohmer V, Vallotton M, Lenoir G, Gaudray P, Proye C, Conte-Devolx B, Chanson P, Shugart YY, Goldgar D, Murat A, Calender A.

Am J Hum Genet. 1998 Aug;63(2):455-67.

8.

Thymic carcinoids in multiple endocrine neoplasia type 1.

Teh BT, Zedenius J, Kytölä S, Skogseid B, Trotter J, Choplin H, Twigg S, Farnebo F, Giraud S, Cameron D, Robinson B, Calender A, Larsson C, Salmela P.

Ann Surg. 1998 Jul;228(1):99-105.

9.

Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics.

Scarpelli D, D'Aloiso L, Arturi F, Scillitani A, Presta I, Bisceglia M, Cristofaro C, Russo D, Filetti S.

J Endocrinol Invest. 2004 Dec;27(11):1015-21.

PMID:
15754732
10.

Clinical testing for multiple endocrine neoplasia type 1 in a DNA diagnostic laboratory.

Klein RD, Salih S, Bessoni J, Bale AE.

Genet Med. 2005 Feb;7(2):131-8.

PMID:
15714081
11.

Clinical Features, Treatments, and Outcomes of Patients with Thymic Carcinoids and Multiple Endocrine Neoplasia Type 1 Syndrome at MD Anderson Cancer Center.

Christakis I, Qiu W, Silva Figueroa AM, Hyde S, Cote GJ, Busaidy NL, Williams M, Grubbs E, Lee JE, Perrier ND.

Horm Cancer. 2016 Aug;7(4):279-87. doi: 10.1007/s12672-016-0269-y. Epub 2016 Jun 16.

PMID:
27311764
12.

A novel deletion of the MEN1 gene in a large family of multiple endocrine neoplasia type 1 (MEN1) with aggressive phenotype.

Raef H, Zou M, Baitei EY, Al-Rijjal RA, Kaya N, Al-Hamed M, Monies D, Abu-Dheim NN, Al-Hindi H, Al-Ghamdi MH, Meyer BF, Shi Y.

Clin Endocrinol (Oxf). 2011 Dec;75(6):791-800. doi: 10.1111/j.1365-2265.2011.04134.x.

PMID:
21627674
13.

Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated hyperparathyroidism.

Cetani F, Pardi E, Giovannetti A, Vignali E, Borsari S, Golia F, Cianferotti L, Viacava P, Miccoli P, Gasperi M, Pinchera A, Marcocci C.

Clin Endocrinol (Oxf). 2002 Apr;56(4):457-64.

PMID:
11966738
14.

Growth hormone-releasing hormone-producing pancreatic neuroendocrine tumor in a multiple endocrine neoplasia type 1 family with an uncommon phenotype.

Sala E, Ferrante E, Verrua E, Malchiodi E, Mantovani G, Filopanti M, Ferrero S, Pietrabissa A, Vanoli A, La Rosa S, Zatelli MC, Beck-Peccoz P, Verga U.

Eur J Gastroenterol Hepatol. 2013 Jul;25(7):858-62. doi: 10.1097/MEG.0b013e32835f433f.

PMID:
23542451
15.

Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation.

Vierimaa O, Ebeling TM, Kytölä S, Bloigu R, Eloranta E, Salmi J, Korpi-Hyövälti E, Niskanen L, Orvola A, Elovaara E, Gynther A, Sane T, Välimäki M, Ignatius J, Leisti J, Salmela PI.

Eur J Endocrinol. 2007 Sep;157(3):285-94.

16.

MEN1 c.825‑1G>A mutation in a family with multiple endocrine neoplasia type 1: A case report.

Ning Z, Wang O, Meng X, Xing X, Xia W, Jiang Y, Li M, Xu Y.

Mol Med Rep. 2015 Oct;12(4):6152-6. doi: 10.3892/mmr.2015.4138. Epub 2015 Jul 29.

PMID:
26239674
17.

Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.

Bartsch DK, Slater EP, Albers M, Knoop R, Chaloupka B, Lopez CL, Fendrich V, Kann PH, Waldmann J.

J Clin Endocrinol Metab. 2014 Nov;99(11):E2387-91. doi: 10.1210/jc.2013-4432. Epub 2014 Sep 11.

PMID:
25210877
18.

Germline mutation of the multiple endocrine neoplasia type 1 (MEN1) gene in a family with primary hyperparathyroidism.

Ohye H, Sato M, Matsubara S, Miyauchi A, Imachi H, Murao K, Takahara J.

Endocr J. 1998 Dec;45(6):719-23.

19.

Characteristics of the Danish families with multiple endocrine neoplasia type 1.

Jäger AC, Friis-Hansen L, Hansen TV, Eskildsen PC, Sølling K, Knigge U, Hansen CP, Andersen PH, Brixen K, Feldt-Rasmussen U, Kroustrup JP, Mollerup CL, Rehfeld JF, Blichert-Toft M, Nielsen FC.

Mol Cell Endocrinol. 2006 Apr 25;249(1-2):123-32. Epub 2006 Mar 23.

PMID:
16563611
20.

Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases.

Tham E, Grandell U, Lindgren E, Toss G, Skogseid B, Nordenskjöld M.

J Clin Endocrinol Metab. 2007 Sep;92(9):3389-95. Epub 2007 Jul 10.

PMID:
17623761

Supplemental Content

Support Center